BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Art Pappas to participate in panel discussion on "The Impact of Globalization in Healthcare" at the North Carolina Biotechnology Center.
News | 08. 15. 2006
